Tandem Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,531
Closed -$266K 91
2025
Q4
$266K Sell
2,531
-570
-18% -$53.5K 0.01% 70
2025
Q3
$260K Buy
3,101
+423
+16% +$34.8K 0.01% 71
2025
Q2
$212K Buy
+2,678
New +$213K 0.01% 66
2025
Q1
Sell
-2,678
Closed -$266K 83
2024
Q4
$266K Sell
2,678
-311
-10% -$32.1K 0.01% 65
2024
Q3
$339K Buy
2,989
+724
+32% +$86K 0.01% 64
2024
Q2
$280K Sell
2,265
-779
-26% -$100K 0.01% 66
2024
Q1
$402K Buy
3,044
+802
+36% +$98.9K 0.02% 60
2023
Q4
$244K Buy
2,242
+256
+13% +$26.6K 0.01% 74
2023
Q3
$204K Buy
+1,986
New +$214K 0.01% 77
2019
Q2
Sell
-2,766
Closed -$219K 68
2019
Q1
$219K Buy
+2,766
New +$207K 0.05% 66

Other funds holding MRK

Tandem Investment Advisors's MRK Position: Q1 2026 in Review

Tandem Investment Advisors sold out of Merck (MRK) in Q1 2026, closing a stake of 2,531 shares — an estimated $266K sold.

Tandem Investment Advisors first reported a position in MRK in Q1 2019 and held it in 10 quarters. The position peaked at $402K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tandem Investment Advisors reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Tandem Investment Advisors sold 2,531 Merck shares in Q1 2026, an estimated $266K.
  • Tandem Investment Advisors first reported a position in Merck in Q1 2019 and held it in 10 quarters.
  • Tandem Investment Advisors's Merck position peaked at $402K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tandem Investment Advisors's 13F filing for Q1 2026, filed 7 May 2026.